Literature DB >> 26110830

Leukemia diagnosis: today and tomorrow.

Marie C Béné1, David Grimwade2, Claudia Haferlach3, Torsten Haferlach3, Gina Zini4.   

Abstract

The European LeukemiaNet (ELN) is composed of several work packages, four of them being directly involved in the various aspects of diagnosis. On the occasion of the annual ELN meeting of 2015 in Mannheim, these four work packages collectively examined the current situation and future prospects of cytomorphology, flow cytometry, cytogenetics, next-generation sequencing, and minimal residual disease detection in the context of leukemia diagnosis and follow-up. This document summarizes the outcome of this compendium.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Mesh:

Year:  2015        PMID: 26110830     DOI: 10.1111/ejh.12603

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  10 in total

1.  Innovation in hematology: morphology and flow cytometry at the crossroads.

Authors:  Marie C Béné; Gina Zini
Journal:  Haematologica       Date:  2016-04       Impact factor: 9.941

2.  Diagnosis of Acute Leukemia by Multiparameter Flow Cytometry with the Assistance of Artificial Intelligence.

Authors:  Pengqiang Zhong; Mengzhi Hong; Huanyu He; Jiang Zhang; Yaoming Chen; Zhigang Wang; Peisong Chen; Juan Ouyang
Journal:  Diagnostics (Basel)       Date:  2022-03-28

Review 3.  Trisomy 21 with t(5; 11) chromosomal translocation as new unfavorable cytogenetic abnormalities in pediatric acute myeloid leukemia type M2: One case report of nine-year follow-up and literature review.

Authors:  Lin Wang; Xiao-Yan Wu; Run-Ming Jin; Bing-Yu Zhang; Yi-Ning Qiu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-10-20

4.  Knockout Of BIRC5 Gene By CRISPR/Cas9 Induces Apoptosis And Inhibits Cell Proliferation In Leukemic Cell Lines, HL60 And KG1.

Authors:  Manizheh Narimani; Mohammadreza Sharifi; Ali Jalili
Journal:  Blood Lymphat Cancer       Date:  2019-11-27

5.  Detailed Characterization of Mesenchymal Stem/Stromal Cells from a Large Cohort of AML Patients Demonstrates a Definitive Link to Treatment Outcomes.

Authors:  Rafael Diaz de la Guardia; Belen Lopez-Millan; Jessie R Lavoie; Clara Bueno; Julio Castaño; Maite Gómez-Casares; Susana Vives; Laura Palomo; Manel Juan; Julio Delgado; Maria L Blanco; Josep Nomdedeu; Alberto Chaparro; Jose Luis Fuster; Eduardo Anguita; Michael Rosu-Myles; Pablo Menéndez
Journal:  Stem Cell Reports       Date:  2017-05-18       Impact factor: 7.765

6.  Network Biomarkers Constructed from Gene Expression and Protein-Protein Interaction Data for Accurate Prediction of Leukemia.

Authors:  Xuye Yuan; Jiajia Chen; Yuxin Lin; Yin Li; Lihua Xu; Luonan Chen; Haiying Hua; Bairong Shen
Journal:  J Cancer       Date:  2017-01-15       Impact factor: 4.207

7.  BIRC5 Gene Disruption via CRISPR/Cas9n Platform Suppress Acute Myelocytic Leukemia Progression

Authors:  Manizheh Narimani; Mohammadreza Sharifi; Mohammad Saeed Hakhamaneshi; Daem Roshani; Mohammad Kazemi; Seyed Hossein Hejazi; Ali Jalili
Journal:  Iran Biomed J       Date:  2019-05-20

8.  Development and Evaluation of a Leukemia Diagnosis System Using Deep Learning in Real Clinical Scenarios.

Authors:  Min Zhou; Kefei Wu; Lisha Yu; Mengdi Xu; Junjun Yang; Qing Shen; Bo Liu; Lei Shi; Shuang Wu; Bin Dong; Hansong Wang; Jiajun Yuan; Shuhong Shen; Liebin Zhao
Journal:  Front Pediatr       Date:  2021-06-24       Impact factor: 3.418

9.  Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.

Authors:  Chun Hang Au; Anna Wa; Dona N Ho; Tsun Leung Chan; Edmond S K Ma
Journal:  Diagn Pathol       Date:  2016-01-22       Impact factor: 2.644

10.  Flow cytometric analysis of CD64 expression pattern and density in the diagnosis of acute promyelocytic leukemia: a multi-center study in Shanghai, China.

Authors:  Min Liu; Xiangqin Weng; Shenglan Gong; Hui Chen; Jing Ding; Mengqiao Guo; Xiaoxia Hu; Jianmin Wang; Jianmin Yang; Gusheng Tang
Journal:  Oncotarget       Date:  2017-09-11
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.